BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 25447983)

  • 1. [Virulence determinant of Chromobacterium violaceum].
    Miki T
    Nihon Saikingaku Zasshi; 2014; 69(4):577-88. PubMed ID: 25447983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Chromobacterium violaceum type III effector CopE, a guanine nucleotide exchange factor for Rac1 and Cdc42, is involved in bacterial invasion of epithelial cells and pathogenesis.
    Miki T; Akiba K; Iguchi M; Danbara H; Okada N
    Mol Microbiol; 2011 Jun; 80(5):1186-203. PubMed ID: 21435035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromobacterium pathogenicity island 1 type III secretion system is a major virulence determinant for Chromobacterium violaceum-induced cell death in hepatocytes.
    Miki T; Iguchi M; Akiba K; Hosono M; Sobue T; Danbara H; Okada N
    Mol Microbiol; 2010 Aug; 77(4):855-72. PubMed ID: 20545857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Production and Uptake of Distinct Endogenous Catecholate-Type Siderophores Are Required for Iron Acquisition and Virulence in Chromobacterium violaceum.
    Batista BB; Santos RERS; Ricci-Azevedo R; da Silva Neto JF
    Infect Immun; 2019 Dec; 87(12):. PubMed ID: 31570563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ferric Uptake Regulator Fur Coordinates Siderophore Production and Defense against Iron Toxicity and Oxidative Stress and Contributes to Virulence in Chromobacterium violaceum.
    Santos RERS; Batista BB; da Silva Neto JF
    Appl Environ Microbiol; 2020 Oct; 86(21):. PubMed ID: 32859594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Global Transcriptional Response to Organic Hydroperoxide and the Role of OhrR in the Control of Virulence Traits in Chromobacterium violaceum.
    Previato-Mello M; Meireles DA; Netto LES; da Silva Neto JF
    Infect Immun; 2017 Aug; 85(8):. PubMed ID: 28507067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful treatment of a patient with recurrent infection of Chromobacterium violaceum.
    Lang L; Wang M; Huang X; Zhou H; Zhou Z; Huang L; Zheng H; Zeng K; Li L
    BMC Infect Dis; 2021 May; 21(1):484. PubMed ID: 34039307
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Batista JH; da Silva Neto JF
    Front Microbiol; 2017; 8():2213. PubMed ID: 29176969
    [No Abstract]   [Full Text] [Related]  

  • 9. Chromobacterium Violaceum Sepsis: Rethinking Conventional Therapy to Improve Outcome.
    Richard KR; Lovvorn JJ; Oliver SE; Ross SA; Benner KW; Kong MY
    Am J Case Rep; 2015 Oct; 16():740-4. PubMed ID: 26477750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromobacterium violaceum: important insights for virulence and biotechnological potential by exoproteomic studies.
    Ciprandi A; da Silva WM; Santos AV; de Castro Pimenta AM; Carepo MS; Schneider MP; Azevedo V; Silva A
    Curr Microbiol; 2013 Jul; 67(1):100-6. PubMed ID: 23455494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phagocyte NADPH oxidase, but not inducible nitric oxide synthase, is essential for early control of Burkholderia cepacia and chromobacterium violaceum infection in mice.
    Segal BH; Ding L; Holland SM
    Infect Immun; 2003 Jan; 71(1):205-10. PubMed ID: 12496167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chromobacterium violaceum and its important metabolites--review.
    Durán M; Faljoni-Alario A; Durán N
    Folia Microbiol (Praha); 2010 Nov; 55(6):535-47. PubMed ID: 21253897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Zinc Transporter ZnuABC Is Critical for the Virulence of Chromobacterium violaceum and Contributes to Diverse Zinc-Dependent Physiological Processes.
    Santos RERS; da Silva Júnior WP; Harrison S; Skaar EP; Chazin WJ; da Silva Neto JF
    Infect Immun; 2021 Oct; 89(11):e0031121. PubMed ID: 34370507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenicity of nonpigmented cultures of Chromobacterium violaceum.
    Sivendra R; Tan SH
    J Clin Microbiol; 1977 May; 5(5):514-6. PubMed ID: 874071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An analysis of type-III secretion gene clusters in Chromobacterium violaceum.
    Betts HJ; Chaudhuri RR; Pallen MJ
    Trends Microbiol; 2004 Nov; 12(11):476-82. PubMed ID: 15488386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromobacterium violaceum infection in Taiwan: a case report and literature review.
    Chang CY; Lee YT; Liu KS; Wang YL; Tsao SM
    J Microbiol Immunol Infect; 2007 Jun; 40(3):272-5. PubMed ID: 17639170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chromobacterium violaceum: The Deadly Sepsis.
    Darmawan G; Kusumawardhani RNY; Alisjahbana B; Fadjari TH
    Acta Med Indones; 2018 Jan; 50(1):80-81. PubMed ID: 29686180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of virulence in
    Venkatramanan M; Nalini E
    Front Microbiol; 2024; 15():1303595. PubMed ID: 38328423
    [No Abstract]   [Full Text] [Related]  

  • 19. A fatal case of pulmonary chromobacterium violaceum infection in an adult.
    Cheong BM
    Med J Malaysia; 2010 Jun; 65(2):148-9. PubMed ID: 23756802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human Chromobacterium violaceum infection in Southeast Asia: case reports and literature review.
    Jitmuang A
    Southeast Asian J Trop Med Public Health; 2008 May; 39(3):452-60. PubMed ID: 18564684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.